DICE Therapeutics, Inc.

DICE · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$461,393$115,826$59,687$8,468
Short-Term Investments$112,832$203,495$0$18,159
Receivables$0$2,000$2,000$2,000
Inventory$0$0$0$0
Other Curr. Assets$3,537$2,590$0$0
Total Curr. Assets$577,762$323,911$62,051$29,093
Property Plant & Equip (Net)$16,018$1,645$1,656$1,927
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$198$198$154$161
Total NC Assets$16,216$1,843$1,810$2,088
Other Assets$0$0$0$0
Total Assets$593,978$325,754$63,861$31,181
Liabilities
Payables$3,075$1,710$5,086$1,006
Short-Term Debt$1,424$480$98$123
Tax Payable$0$0$0$0
Deferred Revenue$0$0$1,125$863
Other Curr. Liab.$10,650$8,691$2,981$1,716
Total Curr. Liab.$15,149$10,881$9,290$3,708
LT Debt$11,841$1,916$0$99
Deferred Rev, NC$0$0$0$1,125
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$8$0$55,872
Total NC Liab.$11,841$1,924$107,716$57,096
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$26,990$12,805$117,006$60,804
Equity
Pref Stock$0$325,754$0$0
Common Stock$5$4$0$0
Retained Earnings-$187,594-$103,707-$54,748-$31,009
AOCI-$597-$58$0$8
Other Equity$592-$325,700$1,603$1,378
Total Equity-$187,594-$103,707-$53,145-$29,623
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity-$160,604-$90,902$63,861$31,181
Net Debt-$448,128-$113,430-$59,589-$8,246